These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25875016)

  • 21. Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
    Reddy P; Maeda Y; Hotary K; Liu C; Reznikov LL; Dinarello CA; Ferrara JL
    Proc Natl Acad Sci U S A; 2004 Mar; 101(11):3921-6. PubMed ID: 15001702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
    Murai M; Yoneyama H; Harada A; Yi Z; Vestergaard C; Guo B; Suzuki K; Asakura H; Matsushima K
    J Clin Invest; 1999 Jul; 104(1):49-57. PubMed ID: 10393698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine profiles in various graft-versus-host disease target organs following hematopoietic stem cell transplantation.
    Lai HY; Chou TY; Tzeng CH; Lee OK
    Cell Transplant; 2012; 21(9):2033-45. PubMed ID: 22840591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
    Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxylated fullerene: a potential antiinflammatory and antioxidant agent for preventing mouse preterm birth.
    Wakimoto T; Uchida K; Mimura K; Kanagawa T; Mehandjiev TR; Aoshima H; Kokubo K; Mitsuda N; Yoshioka Y; Tsutsumi Y; Kimura T; Yanagihara I
    Am J Obstet Gynecol; 2015 Nov; 213(5):708.e1-9. PubMed ID: 26196453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
    Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation.
    Hattori K; Hirano T; Oshimi K; Yagita H; Okumura K
    Leuk Lymphoma; 2000 Aug; 38(5-6):553-61. PubMed ID: 10953977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.
    Saha A; O'Connor RS; Thangavelu G; Lovitch SB; Dandamudi DB; Wilson CB; Vincent BG; Tkachev V; Pawlicki JM; Furlan SN; Kean LS; Aoyama K; Taylor PA; Panoskaltsis-Mortari A; Foncea R; Ranganathan P; Devine SM; Burrill JS; Guo L; Sacristan C; Snyder NW; Blair IA; Milone MC; Dustin ML; Riley JL; Bernlohr DA; Murphy WJ; Fife BT; Munn DH; Miller JS; Serody JS; Freeman GJ; Sharpe AH; Turka LA; Blazar BR
    J Clin Invest; 2016 Jul; 126(7):2642-60. PubMed ID: 27294527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage inflammatory protein-2 (MIP-2)/CXCR2 blockade attenuates acute graft-versus-host disease while preserving graft-versus-leukemia activity.
    Cho KA; Woo SY; Park YS; Park MH; Ryu KH
    Biochem Biophys Res Commun; 2012 Oct; 426(4):558-64. PubMed ID: 22982307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T; Eto M; Lin T; Nishimura Y; Kong YY; Nomoto K; Nomoto K
    J Immunol; 1994 Nov; 153(9):4311-20. PubMed ID: 7930630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.
    Badillo AT; Peranteau WH; Heaton TE; Quinn C; Flake AW
    Br J Haematol; 2008 Apr; 141(2):224-34. PubMed ID: 18318768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cells as effector cells of graft-versus-leukemia activity in a murine transplantation model.
    Uharek L; Glass B; Gaska T; Zeiss M; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S57-60. PubMed ID: 8124260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.
    Yang YG; Sykes M
    Leuk Lymphoma; 1999 May; 33(5-6):409-20. PubMed ID: 10342569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
    Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
    J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.
    van den Brink MR; Moore E; Horndasch KJ; Crawford JM; Murphy GF; Burakoff SJ
    Transplantation; 2000 Jul; 70(1):184-91. PubMed ID: 10919598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into the pathogenesis of GvHD: what mice can teach us about man.
    Hülsdünker J; Zeiser R
    Tissue Antigens; 2015 Jan; 85(1):2-9. PubMed ID: 25532439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.